Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiotensin Receptor Blockers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01202721
What this trial is testing

Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)

Who this might be right for
Cardiac Disease
Hamilton Health Sciences Corporation 85
Post-approval studies (Phase 4)Study completedNCT00720226
What this trial is testing

Efficacy of Losartan in Preventing Progression of COPD

Who this might be right for
COPDEmphysemaChronic Bronchitis+1 more
Johns Hopkins University 106
Not applicableStudy completedNCT01053026
What this trial is testing

Evaluation of Effects of Exercise Training and ARB in DM Patients

Who this might be right for
Vascular FunctionExercise Training
National Taiwan University Hospital 15
Post-approval studies (Phase 4)Study completedNCT04023227
What this trial is testing

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Who this might be right for
Chagas DiseaseHeart Failure
Novartis Pharmaceuticals 922
Post-approval studies (Phase 4)Study completedNCT01675362
What this trial is testing

Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?

Who this might be right for
Kidney Calculi
Mansoura University 160
Large-scale testing (Phase 3)Study completedNCT01195662
What this trial is testing

BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication

Who this might be right for
Type 2 Diabetes
AstraZeneca 2,245
Not applicableUnknownNCT04337190
What this trial is testing

Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)

Who this might be right for
COVIDAcute Respiratory Distress Syndrome
University Hospital, Angers 100
Testing effectiveness (Phase 2)Ended earlyNCT05122182
What this trial is testing

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
University of Sydney 49
Post-approval studies (Phase 4)Ended earlyNCT03686696
What this trial is testing

Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

Who this might be right for
Myocardial Infarction With Non-obstructive Coronary Arteries
Uppsala University 198
Post-approval studies (Phase 4)Study completedNCT00129233
What this trial is testing

Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance

Who this might be right for
HypertensionType 2 Diabetes Mellitus
Nagoya University 1,150
Not applicableUnknownNCT04331574
What this trial is testing

Renin-Angiotensin System Inhibitors and COVID-19

Who this might be right for
COVID-19HypertensionCardiovascular Diseases
Societa Italiana dell'Ipertensione Arteriosa 2,000
Not applicableUnknownNCT04356417
What this trial is testing

Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse

Who this might be right for
AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection
Assistance Publique - Hôpitaux de Paris 6,000,000
Not applicableStudy completedNCT03695120
What this trial is testing

RAAS Optimization for Acute CHF Patients

Who this might be right for
Acute Decompensated Heart Failure
University of Florida 1
Not applicableNot Yet RecruitingNCT07262710
What this trial is testing

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

Who this might be right for
Post-stroke Pneumonia
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13,656
Post-approval studies (Phase 4)Study completedNCT00185120
What this trial is testing

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Who this might be right for
Hypertension
Daiichi Sankyo 152
Not applicableUnknownNCT04374110
What this trial is testing

Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19

Who this might be right for
COVIDHypertensionCardiovascular Diseases+1 more
National Institute of Cardiology, Warsaw, Poland 1,000
Large-scale testing (Phase 3)Looking for participantsNCT05183646
What this trial is testing

The Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Who this might be right for
FSGS
Dimerix Bioscience Pty Ltd 286
Post-approval studies (Phase 4)UnknownNCT01011660
What this trial is testing

Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients

Who this might be right for
Essential Hypertension
Chinese Academy of Medical Sciences, Fuwai Hospital 13,542
Not applicableStudy completedNCT04318418
What this trial is testing

ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19

Who this might be right for
COVID-19
Neuromed IRCCS 3,400
Testing effectiveness (Phase 2)Study completedNCT00939588
What this trial is testing

Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

Who this might be right for
Hypertension
Novartis Pharmaceuticals 88
Next Page